Boulton Named Associate Director, Clinical Research Office and Business Operations

August 29, 2018
By: Karen E. Butler, Director of Communications

Susan Boulton, RN, BSN, previously assistant research practice manager (ARPM) with The Preston Robert Tisch Brain Tumor Center (PRTBTC), was recently named associate director for Duke Cancer Institute’s Clinical Research Office and Business Operations.

“During her time with the brain tumor center, Susan was appointed to various leadership positions in which she consistently excelled,” said Karen Kharasch, director of Research Strategy and Operations and associate director of administration, Duke Cancer Institute. “In her new leadership role with Duke Cancer Institute, Susan will have overall responsibility of the CRU, regulatory, monitoring and auditing, scientific review, finance of the teams and data.”

Boulton, who first joined PRTBTC in 2001, served as ARPM for more than five years. In this role, she oversaw the research practice for neuro-oncology clinical trials focusing on adult and pediatric clinical trials. In August 2017, Boulton assumed the role of interim assistant research practice manager for the Breast Oncology Program.

Previously, from March 2009 to June 2013, Boulton served as clinical trials manager for The Preston Robert Tisch Brain Tumor Center. As clinical trials manager, she managed the clinical trials coordinators, research nurse clinicians, clinical trials assistants, data management staff and regulatory specialists. She had operational oversight for Phase 1 through 3 clinical trials.

Since joining Duke in 1991, Boulton previously has served as a clinical research nurse in many capacities for multiple Duke entities. She received her Bachelor of Science degree in Nursing at the University of North Carolina at Chapel Hill. In 2004, she completed Fundamentals of Clinical Research for CRAs and CRCs at UNC School of Nursing. In 2014, Boulton received the DCI Superstar Award for Lifetime Achievement.

“Moving forward, Susan will work closely and collaboratively with DCI cancer services to administer an integrated research and clinical oncology program at all DCI clinical sites,” said Kharasch.